Is the Mayo Adhesive Probability Score Predictive in Patients Undergoing Percutaneous Nephrolithotomy?
Hakan Bahadir HaberalSema AyvazAli Said KilicalpFahri Erkan SadiogluCagri SenocakOmer Faruk BozkurtPublished in: Journal of laparoendoscopic & advanced surgical techniques. Part A (2024)
Introduction: Mayo Adhesive Probability (MAP) score was developed as a means to predict the presence of adherent perinephric fat. Our aim was to determine the predictive value of the MAP score on surgical outcomes in patients undergoing standard adult percutaneous nephrolithotomy (PCNL). Materials and Methods: We retrospectively analyzed the data from 130 renal units that underwent PCNL between January 2022 and 2023. MAP scores 0-2 were classified as low, whereas MAP scores 3-5 were classified as high. The impact of the MAP score on perioperative and postoperative outcomes was studied. All statistical analyses were performed using SPSS 24.0 for Windows. Results: The median age of the patients at the time of surgery was 48 (21) years, with a female-to-male ratio of 1:1.82. The median MAP score was 2 (2), with 43.8% of patients falling into the high MAP score group. Advanced age, hypertension history, low estimated glomerular filtration rate (eGFR) levels, and low renal parenchymal thickness were significantly higher in the high MAP score group ( P = .010, P = .004, P = .001, and P = .005, respectively). Female patients had a significantly higher MAP score of 0 ( P = .021). Operation time, postoperative hematocrit decrease, blood transfusion rate, postoperative fever rate, hospitalization, and stone-free rates were comparable between the low and high MAP score groups ( P = .535, P = .209, P = .313, P = .289, P = .281, and P = .264, respectively). Gender and eGFR levels were shown to be significant predictors of a MAP ≥3 ( P = .004 and P = .003, respectively). Conclusion: The present study showed that the MAP score groups had similar perioperative and postoperative results. Low eGFR levels and the male gender were associated with MAP score ≥3. To determine the predictive MAP score value for PCNL outcomes, more prospective studies are needed.
Keyphrases
- patients undergoing
- high density
- small cell lung cancer
- end stage renal disease
- minimally invasive
- blood pressure
- newly diagnosed
- type diabetes
- epidermal growth factor receptor
- chronic kidney disease
- adipose tissue
- coronary artery disease
- cardiac surgery
- peritoneal dialysis
- tyrosine kinase
- machine learning
- insulin resistance
- skeletal muscle
- young adults
- artificial intelligence
- patient reported outcomes
- editorial comment